Q4 2021 Holdings
Filed 2022-02-14 | 136 holdings | $742.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Align Technology Inc(ALGN) | COM | 016255101 | $131.4M | 200,000 | 17.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $110.3M | 315,000 | 14.9% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $87.0M | 2,646,625 | 11.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $56.4M | 332,500 | 7.6% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $56.1M | 3,861,347 | 7.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $53.8M | 400,000 | 7.2% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $45.4M | 748,500 | 6.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $37.6M | 457,200 | 5.1% |
| Conmed Corp(CNMD) | COM | 207410101 | $28.7M | 202,500 | 3.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $23.3M | 264,000 | 3.1% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $17.1M | 1,008,114 | 2.3% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $16.9M | 5,328,088 | 2.3% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $13.5M | 725,000 | 1.8% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $13.0M | 538,835 | 1.8% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $10.6M | 1,571,918 | 1.4% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $10.5M | 457,173 | 1.4% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $10.0M | 646,078 | 1.3% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $8.7M | 1,165,582 | 1.2% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $8.3M | 2,215,588 | 1.1% |
| Agilon Health Inc(AGL) | COM | 00857U107 | $202.4K | 7,495,000 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $161.9K | 349,000 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $129.3K | 360,000 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $123.4K | 463,750 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $120.5K | 240,000 | 0.0% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $118.5K | 180,000 | 0.0% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $115.6K | 450,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $94.1K | 1,105,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $92.1K | 859,755 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $84.6K | 2,471,555 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $80.4K | 746,000 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $75.4K | 582,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $74.3K | 883,921 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $74.2K | 1,180,700 | 0.0% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $63.0K | 733,803 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $60.8K | 425,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $60.2K | 410,415 | 0.0% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $60.2K | 1,000,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $57.9K | 714,000 | 0.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $56.4K | 2,038,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $55.9K | 426,843 | 0.0% |
| Freshpet Inc(FRPT) | COM | 358039105 | $55.3K | 580,000 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $53.4K | 1,648,435 | 0.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $51.0K | 433,000 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $47.1K | 742,065 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $44.4K | 570,000 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $42.8K | 2,800,243 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $42.7K | 148,500 | 0.0% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $39.7K | 222,500 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $39.6K | 256,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $38.2K | 424,000 | 0.0% |